AT13148

  • Chemical Properties
CAS No. 1056901-62-2 Cat. No. BCP08961
Name AT13148
Synonyms AT 13148; AT-13148;
Formula C17H16ClN3O M. Wt 313.78
  • Biological Activity
Description AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors. AT13148 is currently being developed by Astex Pharmaceuticals. AT131148 was identified utilizing high-throughput X-ray crystallography and fragment-based lead discovery techniques. AT13148 caused substantial blockade of AKT, p70S6K, PKA, ROCK and SGK substrate phosphorylation and induction of apoptosis in both a concentration and time-dependent manner in cancer cells with clinically relevant genetic defects both in vitro and in vivo.
Pathways Cell Cycle/DNA Damage GPCR/G Protein TGF beta/Smad  Wnt/Stem Cell PI3K/Akt/mTOR MAPK Pathway 
Targets ROCK PKA RSK AKT 

Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
Service & Tech Support:orders@biochempartner.com
Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.